Trial Profile
A Study to Evaluate the Effectiveness of Natalizumab, Fingolimod and Injectable Drugs (Interferon Beta And Glatiramer Acetate) in Non Responders and Treatment-Naive Patients With Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary) ; Natalizumab (Primary) ; Glatiramer acetate; Interferon beta
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 17 Feb 2016 New trial record